What does the literature say about using electronic pillboxes for older adults? A systematic literature review
Clinical studies used commercially well-established electronic pillboxes with a high TRL. New electronic pillboxes in development had a low TRL. The discovered outcome was mainly adherence to medication. The overall mean adherence to medication regimens for all the studies using an electronic pillbo...
- Autores:
-
Cruz , Antonio Miguel
Aya Parra, Pedro Antonio
Bóhorquez, Andrés Felipe
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2018
- Institución:
- Escuela Colombiana de Ingeniería Julio Garavito
- Repositorio:
- Repositorio Institucional ECI
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.escuelaing.edu.co:001/1554
- Acceso en línea:
- https://repositorio.escuelaing.edu.co/handle/001/1554
https://doi.org/10.1080/17483107.2018.1508514
- Palabra clave:
- Pastillero electrónico
Adultos mayores
Electronic pillbox
Older adults
Centered design approach
Pastillero electrónico
Adultos mayores
Enfoque de diseño centrado
- Rights
- closedAccess
- License
- http://purl.org/coar/access_right/c_14cb
Summary: | Clinical studies used commercially well-established electronic pillboxes with a high TRL. New electronic pillboxes in development had a low TRL. The discovered outcome was mainly adherence to medication. The overall mean adherence to medication regimens for all the studies using an electronic pillbox was higher than the gold standard of a good adherence level cut-off point (mean adherence 88.8%>80%). However, we found a large variation in this variable (SD = 10.7). With regard to an older adult population’s adherence to medication regimens, for the outcome variable of those who had undergone a kidney transplant, the clinical evidence that electronic pillboxes have a positive impact was strong (1b); for those with a chronic hepatitis C medical condition, the clinical evidence was medium (3), and for those with arterial hypertension and multiple chronic (diabetes and hypertension) medical conditions, the clinical evidence was weak (5). |
---|